Alpivab
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Peramivir
- Made by
- Biocryst
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Alpivab is indicated for the treatment of uncomplicated influenza in adults and children from the age of 2 years.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
CanadaNo exact match for this strength and form
Details
| Made by | Biocryst |
|---|---|
| Active substance | Peramivir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AH03 · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2018-04-13 |
| Last updated by the regulator | 2020-12-09 |
| EMA product number | EMEA/H/C/004299 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).